MyFinsight
Home
Blog
About
Cash and cash
equivalents
$15,765K
(-23.65%↓ Y/Y)
Prepaid expenses and
other current assets
$1,304K
(-38.95%↓ Y/Y)
Total current assets
$17,069K
(-60.42%↓ Y/Y)
Intangible assets, net
$291K
(-17.80%↓ Y/Y)
Operating lease
right-of-use assets
$104K
(-42.54%↓ Y/Y)
Property and equipment,
net
$36K
(-47.06%↓ Y/Y)
Other non-current
assets
$17K
(0.00%↑ Y/Y)
Total assets
$17,517K
(-59.96%↓ Y/Y)
Total liabilities and
stockholders' equity
$17,517K
(-59.96%↓ Y/Y)
Total liabilities
$9,135K
(-15.60%↓ Y/Y)
Total stockholders'
equity
$8,382K
(-74.54%↓ Y/Y)
Accumulated deficit
-$123,711K
(-26.69%↓ Y/Y)
Total current
liabilities
$9,113K
(-14.66%↓ Y/Y)
Operating lease
liabilities, net of current...
$22K
(-84.83%↓ Y/Y)
Additional paid-in capital
$132,084K
(1.15%↑ Y/Y)
Common stock, 0.001 par
value 150,000,000...
$9K
(0.00%↑ Y/Y)
Accounts payable
$4,638K
(91.26%↑ Y/Y)
Accrued expenses
$4,352K
(-46.56%↓ Y/Y)
Operating lease
liabilities, current portion
$123K
(212.84%↑ Y/Y)
Back
Back
Balance Sheet
Tvardi Therapeutics, Inc. (TVRD)
Tvardi Therapeutics, Inc. (TVRD)
source: myfinsight.com